Effects of antihypertensive treatment in Asian populations: A meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA)

Journal of the American Society of Hypertension

Volumn 8, Issue 2, 2014, Pages 103-116

  Yano, Yuichiro ^a,b   Briasoulis, Alexandros ^a   Bakris, George L ^a   Hoshide, Satoshi ^b   Wang, Ji Guang ^c   Shimada, Kazuyuki ^b   Kario, Kazuomi ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Asia; cardiovascular disease; Hypertension; randomized control trial

Indexed keywords

ASIA; CARDIOVASCULAR DISEASE; HYPERTENSION; RANDOMIZED CONTROL TRIAL;

AGED; ANTIHYPERTENSIVE AGENTS; ASIA; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STROKE;

EID: 84894106176     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.09.002     Document Type: Article

References (54)

1. World Health Organization Media centre. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/index.html. Accessed September 1, 2013.
2. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med 3 2006 e442
3. C.M. Lawes, S. Vander Hoorn, A. Rodgers International Society of Hypertension Global burden of blood-pressure-related disease, 2001 Lancet 371 2008 1513 1518
4. C.M. Lawes, A. Rodgers, D.A. Bennett, V. Parag, I. Suh, H. Ueshima Asia Pacific Cohort Studies Collaboration Blood pressure and cardiovascular disease in the Asia Pacific region J Hypertens 21 2003 707 716
5. H. Arima, Y. Murakami, T.H. Lam, H.C. Kim, H. Ueshima, J. Woo Asia Pacific Cohort Studies Collaboration Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region Hypertension 59 2012 1118 1123
6. H. Ueshima, A. Sekikawa, K. Miura, T.C. Turin, N. Takashima, and Y. Kita et al. Cardiovascular disease and risk factors in Asia: a selected review Circulation 118 2008 2702 2709
7. A.S. Kim, and S.C. Johnston Global variation in the relative burden of stroke and ischemic heart disease Circulation 124 2011 314 323
8. H. Ueshima, X.H. Zhang, and S.R. Choudhury Epidemiology of hypertension in China and Japan J Hum Hypertens 14 2000 765 769
9. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group BMJ 297 1988 319 328
10. B.F. Zhou, J. Stamler, B. Dennis, A. Moag-Stahlberg, N. Okuda, C. Robertson INTERMAP Research Group Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study J Hum Hypertens 17 2003 623 630
11. S. Baba, W.H. Pan, H. Ueshima, H. Ozawa, Y. Komachi, and R. Stamler et al. Blood pressure levels, related factors, and hypertension control status of Japanese and Americans J Hum Hypertens 5 1991 317 332
12. L. Gong, W. Zhang, Y. Zhu, J. Zhu, D. Kong, and V. Pagé et al. Shanghai trial of nifedipine in the elderly (STONE) J Hypertens 14 1996 1237 1245
13. L. Liu, J.G. Wang, L. Gong, G. Liu, and J.A. Staessen Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group J Hypertens 16 12 Pt 1 1998 1823 1829
14. J.G. Wang, J.A. Staessen, L. Gong, and L. Liu Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group Arch Intern Med 160 2000 211 220
15. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group Hypertension 34 1999 1129 1133
16. J.C. Chan, N.M. Wat, W.Y. So, K.S. Lam, C.T. Chua, and K.S. Wong et al. Asian RENAAL Study Investigators. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study Diabetes Care 27 2004 874 879
17. Y. Yui, T. Sumiyoshi, K. Kodama, A. Hirayama, H. Nonogi, K. Kanmatsuse Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial Hypertens Res 27 2004 181 191
18. H. Suzuki, Y. Kanno Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients Hypertens Res 28 2005 307 314
19. L. Liu, Y. Zhang, G. Liu, W. Li, X. Zhang, A. Zanchetti FEVER Study Group The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients J Hypertens 23 2005 2157 2172
20. T. Ogihara, K. Nakao, T. Fukui, K. Fukiyama, K. Ueshima, K. Oba Candesartan Antihypertensive Survival Evaluation in Japan Trial Group Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial Hypertension 51 2008 393 398
21. JATOS Study Group Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) Hypertens Res 31 2008 2115 2127
22. H. Kasanuki, N. Hagiwara, S. Hosoda, T. Sumiyoshi, T. Honda, K. Haze HIJ-CREATE Investigators Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE) Eur Heart J 30 2009 1203 1212
23. L. Liu, Z. Wang, L. Gong, Y. Zhang, L. Thijs, and J.A. Staessen et al. Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature Hypertens Res 32 2009 1032 1040
24. PATS Collaborating Group Post-stroke antihypertensive treatment study. A preliminary result Chin Med J (Engl) 108 1995 710 717
25. T. Ogihara, T. Saruta, H. Rakugi, H. Matsuoka, K. Shimamoto, K. Shimada Valsartan in Elderly Isolated Systolic Hypertension Study Group Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension study Hypertension 56 2010 196 202
26. H. Narumi, H. Takano, S. Shindo, M. Fujita, H. Mizuma, Y. Kuwabara Valsartan Amlodipine Randomized Trial Investigators Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial Hypertens Res 34 2011 62 69
27. M. Matsuzaki, T. Ogihara, S. Umemoto, H. Rakugi, H. Matsuoka, K. Shimada Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial J Hypertens 29 2011 1649 1659
28. E. Imai, J.C. Chan, S. Ito, T. Yamasaki, F. Kobayashi, M. Haneda ORIENT study investigators Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study Diabetologia 54 2011 2978 2986
29. T. Muramatsu, K. Matsushita, K. Yamashita, T. Kondo, K. Maeda, S. Shintani NAGOYA HEART Study Investigators Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study Hypertension 59 2012 580 586
30. H. Ogawa, S. Kim-Mitsuyama, K. Matsui, T. Jinnouchi, H. Jinnouchi, K. Arakawa (OSCAR) Study Group Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients Am J Med 125 2012 981 990
31. K. Iseki, H. Arima, K. Kohagura, I. Komiya, S. Ueda, K. Tokuyama on behalf of the Olmesartan Clinical Trial in Okinawan Patients Under OKIDS (OCTOPUS) Group Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial Nephrol Dial Transplant 28 2013 1579 1589
32. B. Dahlöf, R.B. Devereux, S.E. Kjeldsen, S. Julius, G. Beevers, U. de Faire LIFE Study Group Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003
33. S. Julius, S.E. Kjeldsen, M. Weber, H.R. Brunner, S. Ekman, L. Hansson VALUE trial group Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2004 2022 2031
34. K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlöf, B. Pitt, V. Shi ACCOMPLISH Trial Investigators Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
35. J.P. Higgins, D.G. Altman, P.C. Gotzsche, P. Jüni, D. Moher, A.D. Oxman Cochrane Bias Methods Group; Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
36. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
37. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
38. T. Ogihara, K. Kikuchi, H. Matsuoka, T. Fujita, J. Higaki, M. Horiuchi Japanese Society of Hypertension Committee The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) Hypertens Res 32 2009 3 107
39. American Diabetes Association Standards of medical care in diabetes-2013 Diabetes Care 36 Suppl 1 2013 S11 S66
40. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlöf, D. Elmfeldt, and S. Julius et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 351 1998 1755 1762
41. The ACCORD Study Group Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus N Engl J Med 362 2010 1575 1585
42. M. Banach, and W.S. Aronow Blood pressure j-curve: current concepts Curr Hypertens Rep 14 2012 556 566
43. C.M. Lawes, D.A. Bennett, V.L. Feigin, and A. Rodgers Blood pressure and stroke: an overview of published reviews Stroke 35 2004 776 785
44. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
45. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
46. F. Turnbull, B. Neal, T. Ninomiya, C. Algert, H. Arima, F. Barzi Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials BMJ 336 2008 1121 1123
47. J.A. Staessen, J.G. Wang, and L. Thijs Cardiovascular protection and blood pressure reduction: a meta-analysis Lancet 358 2001 1305 1315
48. J.A. Staessen, J.G. Wang, and L. Thijs Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003 J Hypertens 21 2003 1055 1076
49. R.B. Singh, I.L. Suh, V.P. Singh, S Chaithiraphan, P. Laothavorn, and RG Sy et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 14 2000 749 763
50. C. Pristipino, J.F. Beltrame, M.L. Finocchiaro, R. Hattori, M. Fujita, and R. Mongiardo et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction Circulation 101 2000 1102 1108
51. J.G. Wang, K. Kario, T. Lau, Y.Q. Wei, C.G. Park, C.H. Kim Asian Pacific Heart Association Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association Hypertens Res 34 2011 423 430
52. H. Mori, H. Ukai, H. Yamamoto, S. Saitou, K. Hirao, and M. Yamauchi et al. Current status of antihypertensive prescription and associated blood pressure control in Japan Hypertens Res 29 2006 143 151
53. S. Yusuf, S. Reddy, S. Ounpuu, and S. Anand Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies Circulation 104 2001 2855 2864
54. R. Gupta, V.P. Gupta, N. Bhagat, P. Rastogi, M. Sarna, and H. Prakash et al. Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies Indian Heart J 60 2008 26 33